TWST News and Press, Twist Bioscience Corporation From 04/27/23

2023-04-27 11:52:07 ET Twist Bioscience ( NASDAQ: TWST ) and Aster Insights are launching a next generation oncology panel AsterExome for cancer research. The company said the panel can simultaneously enable whole exome sequencing (WES) with additional coverage for target regi...

Comprehensive capture panel to enable enhanced bioinformatics-based oncology research Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Aster Insights , a bioinf...

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura., “Astellas”...

TCR and CAR libraries enable comprehensive screening of combinations of custom gene parts including domains from TCRs and CARs Information about the offering available at AACR Annual Meeting 2023 Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to su...

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2023 second quarter ended March 31, 2023, before the opening ...

Storage Veteran Appointments Bring Diverse Technical Expertise to Help Lead Implementation of Industry Standards for DNA Data Storage The DNA Data Storage Alliance, a SNIA Technology Affiliate, formed in 2020 by Illumina, Inc. (NASDAQ: ILMN), Microsoft (Nasdaq: MSFT), Twist Bios...

2023-03-17 16:16:22 ET Summary Here's a long list of biopharmas exposed to SVB Financial Group. Many of these deposits will be uninsured. However, since SVB Financial Group was quite solvent otherwise, much of these deposits should be recoverable by these small companies. ...

SAN DIEGO, CA / ACCESSWIRE / March 14, 2023 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Twist Bioscience Corporation (NASDAQ:TWST). Investors who purchased shares of Twist Bioscience Corporation (NASDAQ:TWST) prior to December 2019 ...

-- Integrated offering to be highlighted at Festival of Biologics -- -- Tracey Mullen, MBA, to lead Twist Biopharma Solutions -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silico...

2023-03-08 11:36:51 ET Summary Ongoing losses are likely to continue weighing on the stock, particularly as the Portland site starts up and begins to drag on gross profit margins. 2024 is potentially setting up to be a more positive year for Twist, with the launch of their data st...